These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33915863)

  • 21. Extraction and purification methods in downstream processing of plant-based recombinant proteins.
    Łojewska E; Kowalczyk T; Olejniczak S; Sakowicz T
    Protein Expr Purif; 2016 Apr; 120():110-7. PubMed ID: 26742898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging trends in pulmonary delivery of biopharmaceuticals.
    Kunde SS; Ghosh R; Wairkar S
    Drug Discov Today; 2022 May; 27(5):1474-1482. PubMed ID: 35143963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
    Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
    J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edible plants for oral delivery of biopharmaceuticals.
    Merlin M; Pezzotti M; Avesani L
    Br J Clin Pharmacol; 2017 Jan; 83(1):71-81. PubMed ID: 27037892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Rebif new formulation story: it's not trials and error.
    Jaber A; Driebergen R; Giovannoni G; Schellekens H; Simsarian J; Antonelli M
    Drugs R D; 2007; 8(6):335-48. PubMed ID: 17963425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production.
    Shanmugaraj B; I Bulaon CJ; Phoolcharoen W
    Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32635427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
    Cun D; Wan F; Yang M
    Curr Pharm Des; 2015; 21(19):2599-610. PubMed ID: 25876915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon production by Viral, Bacterial & Yeast system: A comparative overview in 2023.
    Raghuvanshi V; Yadav P; Ali S
    Int Immunopharmacol; 2023 Jul; 120():110340. PubMed ID: 37230033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in biopharmaceutical development.
    Kesik-Brodacka M
    Biotechnol Appl Biochem; 2018 May; 65(3):306-322. PubMed ID: 28972297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial carbohydrate-binding toxins - From etiology to biotechnological application.
    Danielewicz N; Rosato F; Dai W; Römer W; Turnbull WB; Mairhofer J
    Biotechnol Adv; 2022 Oct; 59():107951. PubMed ID: 35398203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
    Curti E; Seid CA; Hudspeth E; Center L; Rezende W; Pollet J; Kwityn C; Hammond M; Matsunami RK; Engler DA; Hotez PJ; Elena Bottazzi M
    Hum Vaccin Immunother; 2014; 10(7):1914-25. PubMed ID: 25424799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
    Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
    J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in chromatographic purification of biopharmaceuticals.
    Rathore AS; Kumar D; Kateja N
    Biotechnol Lett; 2018 Jun; 40(6):895-905. PubMed ID: 29700726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hot melt extrusion: An emerging manufacturing method for slow and sustained protein delivery.
    Zheng Y; Pokorski JK
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1712. PubMed ID: 33691347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current trends in biopharmaceuticals production in Escherichia coli.
    McElwain L; Phair K; Kealey C; Brady D
    Biotechnol Lett; 2022 Aug; 44(8):917-931. PubMed ID: 35796852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
    Buckley K; Ryder AG
    Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oligonucleotides: Current Trends and Innovative Applications in the Synthesis, Characterization, and Purification.
    Catani M; De Luca C; Medeiros Garcia Alcântara J; Manfredini N; Perrone D; Marchesi E; Weldon R; Müller-Späth T; Cavazzini A; Morbidelli M; Sponchioni M
    Biotechnol J; 2020 Aug; 15(8):e1900226. PubMed ID: 32298041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications.
    Cioni P; Gabellieri E; Campanini B; Bettati S; Raboni S
    Curr Med Chem; 2022; 29(3):411-452. PubMed ID: 34259137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.